EA201300394A1 - ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) - Google Patents

ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)

Info

Publication number
EA201300394A1
EA201300394A1 EA201300394A EA201300394A EA201300394A1 EA 201300394 A1 EA201300394 A1 EA 201300394A1 EA 201300394 A EA201300394 A EA 201300394A EA 201300394 A EA201300394 A EA 201300394A EA 201300394 A1 EA201300394 A1 EA 201300394A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
options
therapeutic effect
antioxidant
antioxidant pharmaceutical
Prior art date
Application number
EA201300394A
Other languages
Russian (ru)
Inventor
Анастасия Геннадьевна ЧЕЛЯЕВА
Владимир Павлович ЛОБКО
Original Assignee
Ооо "Фармацевтическая Компания "Славянская Аптека"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ооо "Фармацевтическая Компания "Славянская Аптека" filed Critical Ооо "Фармацевтическая Компания "Славянская Аптека"
Priority to EA201300394A priority Critical patent/EA201300394A1/en
Publication of EA201300394A1 publication Critical patent/EA201300394A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к области фармацевтической промышленности, медицине. Задачей настоящего изобретения является создание эффективного антиоксидантного фармацевтического состава. Задача решается за счет того, что антиоксидантный фармацевтический состав, содержащий метилэтилпиридинола гидрохлорид, дополнительно содержит минеральные вещества: натрий, калий, кальций, железо, марганец, цинк, а также содержит изотопы углеродаС и изотопы азотаN. Изобретение описано в четырех вариантах реализации. Техническими результатами изобретения являются увеличение срока годности фармацевтического состава; увеличение лечебного эффекта, а также скорости наступления лечебного эффекта.The invention relates to the field of pharmaceutical industry, medicine. The present invention is the creation of an effective antioxidant pharmaceutical composition. The problem is solved due to the fact that the antioxidant pharmaceutical composition containing methyl ethyl pyridinol hydrochloride additionally contains minerals: sodium, potassium, calcium, iron, manganese, zinc, and also contains carbon isotopes and nitrogen isotopesN. The invention is described in four embodiments. The technical results of the invention are to increase the shelf life of the pharmaceutical composition; increase therapeutic effect, as well as the rate of onset of therapeutic effect.

EA201300394A 2013-04-22 2013-04-22 ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) EA201300394A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA201300394A EA201300394A1 (en) 2013-04-22 2013-04-22 ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201300394A EA201300394A1 (en) 2013-04-22 2013-04-22 ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)

Publications (1)

Publication Number Publication Date
EA201300394A1 true EA201300394A1 (en) 2014-10-30

Family

ID=51794635

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201300394A EA201300394A1 (en) 2013-04-22 2013-04-22 ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)

Country Status (1)

Country Link
EA (1) EA201300394A1 (en)

Similar Documents

Publication Publication Date Title
JO3438B1 (en) Aryl- or heteroaryl-substituted benzene compounds
EA201391285A1 (en) Derivatives of tetrahydroquinoline, useful as bromodomain inhibitors
EA201591591A1 (en) COMPOUNDS OF CARBAZOLE APPLIED AS Bromodomain Inhibitors
EA028156B9 (en) Fused heterocyclic compounds as ion channel modulators
NZ720651A (en) Fused heterocyclic compounds as ion channel modulators
EA201300394A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300371A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300376A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300393A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300392A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300378A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300377A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300372A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300370A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300373A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201200359A1 (en) PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS)
EA201200858A1 (en) PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS)
EA201200343A1 (en) PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS)
EA201200315A1 (en) PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS)
EA201200337A1 (en) PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS)
EA201200339A1 (en) PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS)
EA201200311A1 (en) PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS)
EA201200314A1 (en) PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS)
EA201200313A1 (en) PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS)
EA201201215A1 (en) PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS)